lobbying_filings_raw: cc7ef99f-3bfc-4e87-b07d-1b435c19125d
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cc7ef99f-3bfc-4e87-b07d-1b435c19125d | Q3 | 40036301 | KNIGHT CAPITOL CONSULTANTS | 188333 | SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC ) | 2013 | third_quarter | 2013-10-16T19:03:19.287000-04:00 | 30000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/cc7ef99f-3bfc-4e87-b07d-1b435c19125d/", "filing_uuid": "cc7ef99f-3bfc-4e87-b07d-1b435c19125d", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2013, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/cc7ef99f-3bfc-4e87-b07d-1b435c19125d/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Patricia Knight, President", "dt_posted": "2013-10-16T19:03:19.287000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "750 17th Street, NW, Suite 1100", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington,", "registrant_state": "DC", "registrant_zip": "20006", "registrant": {"id": 40036301, "url": "https://lda.senate.gov/api/v1/registrants/40036301/", "house_registrant_id": 39935, "name": "KNIGHT CAPITOL CONSULTANTS", "description": "Government Relations", "address_1": "817 North Lincoln Street", "address_2": null, "address_3": null, "address_4": null, "city": "Arlington", "state": "VA", "state_display": "Virginia", "zip": "22201", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "PATRICIA KNIGHT", "contact_telephone": "+1 202-510-5264", "dt_updated": "2026-03-04T13:51:53.437656-05:00"}, "client": {"id": 188333, "url": "https://lda.senate.gov/api/v1/clients/188333/", "client_id": 36, "name": "SANOFI US SERVICES INC (FORMERLY KNOWN AS \"SANOFI-AVENTIS U S INC )", "general_description": "Pharmaceutical research and development", "client_government_entity": false, "client_self_select": false, "state": "NJ", "state_display": "New Jersey", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2008-02-01"}, "lobbying_activities": [{"general_issue_code": "MAN", "general_issue_code_display": "Manufacturing", "description": "Drug Quality and Security Act (H.R. 3204; S. 959)", "foreign_entity_issues": "Sanofi U.S. Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi U.S. Services Inc., so, too, Sanofi SA, as the parent corporation, will benefit.", "lobbyists": [{"lobbyist": {"id": 40329, "prefix": null, "prefix_display": null, "first_name": "PATRICIA", "nickname": null, "middle_name": null, "last_name": "KNIGHT", "suffix": null, "suffix_display": null}, "covered_position": "Professional Staff, House Approps Cmte", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "ECN", "general_issue_code_display": "Economics/Economic Development", "description": "Foreign direct investment in the United States, including the Global Investment in American Jobs Act (HR 2052/ S. 1023)", "foreign_entity_issues": "Sanofi U.S. Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi U.S. Services Inc., so, too, Sanofi SA, as the parent corporation, will benefit.", "lobbyists": [{"lobbyist": {"id": 40329, "prefix": null, "prefix_display": null, "first_name": "PATRICIA", "nickname": null, "middle_name": null, "last_name": "KNIGHT", "suffix": null, "suffix_display": null}, "covered_position": "(previously listed)", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Monitor possible changes in the tax code affecting corporations, including corporate income tax reform and a strengthened U.S. R&D tax credit.", "foreign_entity_issues": "Sanofi U.S. Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi U.S. Services Inc., so, too, Sanofi SA, as the parent corporation, will benefit.", "lobbyists": [{"lobbyist": {"id": 40329, "prefix": null, "prefix_display": null, "first_name": "PATRICIA", "nickname": null, "middle_name": null, "last_name": "KNIGHT", "suffix": null, "suffix_display": null}, "covered_position": "Previously Listed", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "User fee sequester/implementation issues related to PL 112-144; changes to the Affordable Care Act (PL 111-148)/Health Care & Education Reconciliation Act (PL 111-152), including Independent Payment Advisory Board; compounding of human/animal drugs (Pharmaceutical Compounding Quality and Accountability Act, S. 959); School Access to Emergency Epinephrine Act (H.R. 2094/ S. 1503)", "foreign_entity_issues": "Sanofi U.S. Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi U.S. Services Inc., so, too, Sanofi SA, as the parent corporation, will benefit.", "lobbyists": [{"lobbyist": {"id": 40329, "prefix": null, "prefix_display": null, "first_name": "PATRICIA", "nickname": null, "middle_name": null, "last_name": "KNIGHT", "suffix": null, "suffix_display": null}, "covered_position": "previously listed", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to changes in the Medicare Part B reimbursement of prescription drugs; and issues related to coverage and reimbursement for the Medicare and Medicaid programs, including the Part D prescription drug benefit (no specific legislation).", "foreign_entity_issues": "Sanofi U.S. Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi U.S. Services Inc., so, too, Sanofi SA, as the parent corporation, will benefit.", "lobbyists": [{"lobbyist": {"id": 40329, "prefix": null, "prefix_display": null, "first_name": "PATRICIA", "nickname": null, "middle_name": null, "last_name": "KNIGHT", "suffix": null, "suffix_display": null}, "covered_position": "previously listed", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Effect of sequester on public health programs, biomedical research, and the Food and Drug Administration (FY 2014 appropriations for FDA-H.R. 2410/S. 1244/FY 2014 appropriations for HHS- S. 1284/Continuing Resolution H.J. Res. 59).", "foreign_entity_issues": "Sanofi U.S. Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi U.S. Services Inc., so, too, Sanofi SA, as the parent corporation, will benefit.", "lobbyists": [{"lobbyist": {"id": 40329, "prefix": null, "prefix_display": null, "first_name": "PATRICIA", "nickname": null, "middle_name": null, "last_name": "KNIGHT", "suffix": null, "suffix_display": null}, "covered_position": "previously listed", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |